Search results
Results from the WOW.Com Content Network
Bictegravir (BIC) is an integrase strand transfer inhibitor (INSTI). Bictegravir is different from other INSTIs because it contains a bridged bicyclic ring and a distinct benzyl tail with a 2,4,6-trifluorobenzyl group.
Tablets are often imprinted with symbols, letters, and numbers, which allow them to be identified, or a groove to allow splitting by hand. Sizes of tablets to be swallowed range from a few millimetres to about a centimetre. The compressed tablet is the most commonly seen dosage form in use today.
Alogliptin, sold under the brand names Nesina and Vipidia, [2] [3] is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class. [4] Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. [1]
The term dosage form may also sometimes refer only to the pharmaceutical formulation of a drug product's constituent substances, without considering its final configuration as a consumable product (e.g., capsule, patch, etc.). Due to the somewhat ambiguous nature and overlap of these terms within the pharmaceutical industry, caution is ...
According to the health regulator's website, 10, 12.5 and 15 milligram doses of the injection will have limited availability, while lower doses of Mounjaro were shown to be available. Eli Lilly ...
Tablet: 5–20 mg/day Metandienone b: Dianabol: Tablet: 5–15 mg/day Mesterolone b: Proviron: Tablet: 25–150 mg/day Sublingual: Testosterone b: Testoral: Tablet: 5–10 mg 1–4×/day Methyltestosterone b: Metandren, Oreton Methyl: Tablet: 10–30 mg/day Buccal: Testosterone: Striant: Tablet: 30 mg 2×/day Methyltestosterone b: Metandren ...
25–50 mg/day Enzalutamide: Xtandi: Antiandrogen: Oral: 160 mg/day GnRH analogue: Various: GnRH modulator: Various: Variable Elagolix: Orilissa: GnRH antagonist: Oral: 150 mg/day or 200 mg twice daily Finasteride: Propecia: 5αR inhibitor: Oral: 1–5 mg/day Dutasteride: Avodart: 5αR inhibitor: Oral: 0.25–0.5 mg/day Progesterone: Prometrium ...
[39] [40] It is available in 50 mg, 80 mg (in Japan), [48] and 150 mg tablets for oral administration. [ 82 ] [ 83 ] The drug is registered for use as a 150 mg/day monotherapy for the treatment of LAPC in at least 55 countries, [ 2 ] with the U.S. being a notable exception where it is registered only for use at a dosage of 50 mg/day in ...